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Myoepithelial cells are usually present be-tween the epithelial cells and the basal lam-ina of the secretory elements of the mam-
mary duct system of the breast.1 Tumors derived from 
these cells are found in the skin, lungs, salivary glands 
and breast. Neoplasms of the myoepithelium are called 
myoepitheliomas, which may be benign or malignant. 
Tumors that arise from both epithelium and myoepi-
thelial cells are called adenomyoepithelioma (AME). 
Adenomyoepithelioma of the breast is a rare entity. 
Although it is a benign tumor, locoregional recurrences 
and distant metastasis have also been reported.1,2 Total 
surgical excision of the tumor with adequate margin and 
long-term follow-up is the treatment recommended for 
AME.3,4 We report a case report on AME of the right 
breast that merits documentation due to its rarity.
CASE
A 50-year-old female presented clinically with breath-
lessness of one month duration during April 2007. 
On review of her past history, she had presented with 
a painless mobile lump of size 8×7 cm at the upper, 
outer aspect of the right breast without fixation to skin 
and underlying structures in September 2004. There 
was no involvement of the right axillary or supracla-
vicular lymph nodes. The family history of the patient 
was unremarkable. Fine needle aspiration cytology and 
core biopsy of the breast lump showed ductal carci-
noma. Routine hematological parameters, chest x-ray 
posterior-anterior view and ultrasound of the abdo-
men were normal. She had undergone modified radical 
mastectomy due to diagnosis of ductal carcinoma of the 
right breast. Histopathology examination of the pri-
mary lesion revealed solid sheets of round, oval spindle 
cells at places forming the outer layer of some glands. 
Many small tubular glands within the cell nests lined 
by columnar epithelial cells were present. A few glands 
also showed apocrine activity. Dense hyaline material 
was seen around the glands. Focal increase in cellular-
ity, mild to moderate cellular atypia with small foci of 
necrosis and low mitotic activity was noted (Figures 
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1, 2). The base of the excision was free. Nipple, areola 
and adjacent breast tissue was normal. Similary axil-
lary lymphnodes on histopathology, did not reveal any 
malignancy. The resected specimen was subjected for 
immunohistochemistry (IHC) study and it was posi-
tive for S-100 protein, SMA and cytokeratin. Based 
on clinical, histopathology and IHC report, the patient 
was diagnosed as having AME of the right breast. She 
was on follow-up at 3 months interval for first year 
and six months interval thereafter. Her routine clinical 
evaluation, x-ray chest and ultrasound of abdomen and 
pelvis were within normal limit up to September 2006. 
During April 2007, she presented with breathlessness 
for which she was evaluated and her CT scan of the 
thorax revealed a mass occupying the right hemitho-
rax (Figure 3). Hematological and biochemical profiles 
of the patient were within normal limits. A metastatic 
workup did not reveal any other distant metastasis ex-
cept lung involvement. Core needle biopsy of the lesion 
of thorax revealed similar histopathology as that of the 
breast lesion. The patient was treated with 6 cycles of 
combination chemotherapy consisting of cyclophospha-
mide 600 mg/m2, epirubicin 90 mg/m2, 5-fluorouracil 
600 mg/m2 on D1 at 3-week intervals. She achieved 
partial response at the completion of six cycles of the 
treatment. Subsequently, she died due to persistence of 
the metastatic disease.
DISCUSSION
AME of the breast was first described by Hamperl 
in 1970.5 AME patients are usually elderly and pres-
ent with a solitary, nodular palpable mass which is well 
circumscribed.6 The average size of the lesion is 2.5 
cm and is mostly centrally located. The present case 
was a 50-year-old female who presented with a lesion 
of size 8×7 cm at the upper outer aspect of the right 
breast. The histogenesis of this tumor is unclear, but it 
has been suggested that it derives from myoepithelial 
overgrowth of long standing adenosis, fibroadenoma 
or other benign breast lesion which proceeds to benign 
adenomyoepithelioma and ends in a malignant tumor 
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that still may contain residues of its precursor lesion.6 
Three types of lesions, i.e. myoepithelioma, adenomyo-
epithelioma and myoepithelial carcinoma, arise from 
myoepithelial cell of the breast. AME is composed of 
a proliferating ductal epithelial and myoepithelial cells 
in a bilaminar pattern.7 AME histologically is subclas-
sified as spindle cell type, lobulated, tubular type and 
a combination of the above. These different histologi-
cal subtypes behave differently in clinical presentation 
and follow up. The histopathology of AME appears 
to be of ductal structures composed of an inner layer 
of epithelial cells with eosinophilic cytoplasm and a 
prominent peripheral layer of myoepithelial cells with 
clear cytoplasm. The majority of the tumors have low 
mitotic activity (mitotic figures less than 3/10 high-
power field). Associated focal apocrine, squamous 
or chondroid and osseous metaplasia may be seen. A 
patient with AME presenting with high mitotic activ-
ity, cellular pleomorphism, and infiltrating border are 
suggestive of malignancy.8-10 Malignant changes may 
involve only one cellular element and more frequently 
epithelial rather than a myoepithelial component. On 
immunohistochemistery, myoepithelial cells exhibit 
positive reactions for SMA, smooth muscle myosin, vi-
mentin, EMA, S-100 protein, while luminal epithelial 
cells are positive for cytokeratin, EMA and CEA.
The reported case presented with small tubular 
glands lined by columnar epithelial cells with surround-
ing solid sheets of round, oval spindle cells at places 
forming the outer layer of these glands. Therefore, this 
case was a combination of tubular and spindloid variety 
of AME. The present case had SMA, S-100 and cyto-
keratin positivity.
Other prolliferative breast lesions like sclerosing 
adenosis, fibroadenoma and tubular adenoma having 
epithelial and myoepithelial components can be con-
sidered in the differential diagnosis of AME. Lack of 
lobulocentric architecture rules out the sclerosing ad-
enosis. Solid sheets of round, oval spindle cells exclude 
the probability of fibroadenoma and tubular adenoma.
In a review of the literature, all cases of AME are 
sporadic and no familial aggregation has been observed. 
None of the first-degree relatives of the patient have 
been reported with similar presentation.
Even though AME appears benign, local recurrence, 
nodal and distant metastasis have also been reported. 
The best predictor of local recurrence is an initial in-
complete resection due to multinodularity and periph-
eral intraductal extension of the tumor.2 Hence, com-
plete surgical excision with wide margins is required.11 
Various cases have been reported in the literature where 
sampling or dissection of the axillary lymph nodes has 
Figure 1. Photomicrograph showing sheets and cords of round, 
oval spindle cells forming the outer layer of some glands at 
places. Occasional tubular glands within these nests are 
lined by columnar cells. Focal increase cellularity and cellular 
pleomorphism (He ×100). 
Figure 2. Photomicrograph showing solid sheets and cords of 
oval cells with mild nuclear pleomorphism and occasional mitotic 
figures (He ×400). 
Figure 3. CT scan thorax showing mass in the left hemithorax.
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been performed as a part of the initial surgery, while 
sentinel node biopsy as a part of this initial procedure 
has not been mentioned.12 Since, axillary nodal involve-
ment is rare, axillary intervention may be considered an 
overtreatment in most cases and hence it is desirable to 
perform sentinel node biopsy even in cases with swollen 
nodes in the ipsilateral axilla.12
Patients with a rapid increase in size of tumor, poor-
ly defined margins, marked distortion of the surround-
ing breast parenchyma, high cellularity and high mitotic 
activity should be suspected of malignancy. Having po-
tent metastatic characterstics, AME is prone to spread 
hematogenously, especially when the tumor size is more 
than 2 cm. The metastasis may involve one or both the 
cellular components. Distant metastasis to the lung, 
liver, brain, bone, thyroid, chestwall and lymph nodes 
has been reported.13-15
Histologically, if a carcinomatous element is identi-
fied in an excised AME, it should be treated as a carci-
noma.16 Mastectomy with breast irradiation and axil-
lary dissection are not appropriate for benign AME.17 
Atilli et al reported a case of aggressive AME where the 
patient had undergone a modified radical mastectomy 
(MRM), received local radiation to the chestwall and 
six courses of anthracycline-based chemotherapy. The 
tumor showed good chemosensitivity with the patient 
being in complete remission at 18 months follow-up.18
Due to the initial diagnosis of carcinoma, MRM 
was done in the present case. However, on histopathol-
ogy, after MRM, it was diagnosed as AME for which 
no further treatment was given. With the radical sur-
gery, no local recurrence was encountered until the pa-
tient died of metastatic disease. Due to subsequent de-
velopment of pulmonary metastasis she was given six 
courses of anthracycline-based (CEF) chemotherapy 
and attained a partial response. Whether the distant 
metastasis in this case could have been prevented by 
giving systemic adjuvant chemotherapy is unclear, but 
the appropriate indications and chemoregimen is yet 
to be defined in patients with AME. Patients with 
marked distortion of the surrounding breast paren-
chyma, high mitotic activity, high cellularity and con-
sidering the epithelial or myoepithelial component of 
the breast lesion, these patients should be subjected to 
anthracycline-based chemotherapy.
In conclusion, AME is an unusual breast tumor. 
With the awareness of the disease and meticulous 
histopathological observations of proliferating solid 
sheets of round, ovoid to spindloid myoepithelial 
cells around small tubular glands lined by columnar 
cells excludes the possibilities of duct or lobular car-
cinoma. Complete excision of the tumor is necessary 
for accurate diagnosis and definitive treatment, avoid-
ing unnecessary mastectomy and axillary dissection. 
Although considered an indolent neoplasm, it can 
show local recurrence and rarely distant metastasis. 
Malignant transformation of one or both the compo-
nents of AME may occur. Patients with AME present-
ing with marked distortion of the surrounding breast 
parenchyma, high mitotic activity, high cellularity and 
necrosis should be subjected to anthracycline-based 
combination chemotherapy.
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